These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 18350718)
1. [Can measurement of CRP and BNP concentrations be helpful in predicting relapses and therapy of atrial fibrillation?]. Mikółka R Wiad Lek; 2007; 60(9-10):439-44. PubMed ID: 18350718 [TBL] [Abstract][Full Text] [Related]
2. C-reactive protein but not atrial dysfunction predicts recurrences of atrial fibrillation after cardioversion in patients with preserved left ventricular function. Lombardi F; Tundo F; Belletti S; Mantero A; Melzi D'eril GV J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):581-8. PubMed ID: 18475126 [TBL] [Abstract][Full Text] [Related]
3. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro) BNP. Shelton RJ; Goode K; Cleland JG Europace; 2007 Feb; 9(2):147; author reply 148. PubMed ID: 17227813 [No Abstract] [Full Text] [Related]
4. Effects of exercise testing on natriuretic peptide secretion in patients with atrial fibrillation. Wozakowska-Kapłon B; Opolski G Kardiol Pol; 2009 Mar; 67(3):254-61. PubMed ID: 19378231 [TBL] [Abstract][Full Text] [Related]
5. [The contribution of inflammatory process in pathogenesis and natural history of atrial fibrillation]. Zyśko D; Gajek J; Mazurek W Pol Merkur Lekarski; 2005 Feb; 18(104):227-8. PubMed ID: 17877137 [TBL] [Abstract][Full Text] [Related]
6. Derived fibrinogen compared with C-reactive protein and brain natriuretic peptide for predicting events after myocardial infarction and coronary stenting. Ketch TR; Turner SJ; Sacrinty MT; Lingle KC; Applegate RJ; Kutcher MA; Sane DC Am Heart J; 2008 Aug; 156(2):234-40. PubMed ID: 18657651 [TBL] [Abstract][Full Text] [Related]
7. Long-term prognostic value of baseline C-reactive protein in predicting recurrence of atrial fibrillation after electrical cardioversion. Korantzopoulos P; Kalantzi K; Siogas K; Goudevenos JA Pacing Clin Electrophysiol; 2008 Oct; 31(10):1272-6. PubMed ID: 18811807 [TBL] [Abstract][Full Text] [Related]
8. Heart failure may be associated with the onset of ischemic stroke with atrial fibrillation: a brain natriuretic peptide study. Shibazaki K; Kimura K; Okada Y; Iguchi Y; Terasawa Y; Aoki J J Neurol Sci; 2009 Jun; 281(1-2):55-7. PubMed ID: 19321180 [TBL] [Abstract][Full Text] [Related]
10. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently. Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587 [TBL] [Abstract][Full Text] [Related]
11. The predictive value of plasma brain natriuretic peptide for the recurrence of atrial fibrillation six months after external cardioversion. Ari H; Binici S; Ari S; Akkaya M; Koca V; Bozat T; Gürdoğan M Turk Kardiyol Dern Ars; 2008 Oct; 36(7):456-60. PubMed ID: 19155659 [TBL] [Abstract][Full Text] [Related]
13. Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting. Ata Y; Turk T; Ay D; Eris C; Demir M; Ari H; Ata F; Yavuz S; Ozyazicioglu A Heart Surg Forum; 2009 Aug; 12(4):E211-6. PubMed ID: 19683991 [TBL] [Abstract][Full Text] [Related]
14. The use of B-type natriuretic peptide in the management of patients with atrial fibrillation and dyspnea. Breidthardt T; Noveanu M; Cayir S; Viglino M; Laule K; Hochholzer W; Reichlin T; Potocki M; Christ M; Mueller C Int J Cardiol; 2009 Aug; 136(2):193-9. PubMed ID: 18619686 [TBL] [Abstract][Full Text] [Related]
15. Utility of brain natriuretic peptide as a predictor of atrial fibrillation after cardiac operations. Tavakol M; Hassan KZ; Abdula RK; Briggs W; Oribabor CE; Tortolani AJ; Sacchi TJ; Lee LY; Heitner JF Ann Thorac Surg; 2009 Sep; 88(3):802-7. PubMed ID: 19699901 [TBL] [Abstract][Full Text] [Related]
17. Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation? Tang RB; Dong JZ; Liu XP; Ma CS Med Hypotheses; 2006; 67(3):462-6. PubMed ID: 16793213 [TBL] [Abstract][Full Text] [Related]
18. Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Aguiar-Souto P; Toquero-Ramos J; Fernández-Lozano I Pacing Clin Electrophysiol; 2006 Dec; 29(12):1452. PubMed ID: 17201859 [No Abstract] [Full Text] [Related]
19. Evaluating the role of biomarkers for cardiovascular risk prediction: focus on CRP, BNP and urinary microalbumin. May A; Wang TJ Expert Rev Mol Diagn; 2007 Nov; 7(6):793-804. PubMed ID: 18020909 [TBL] [Abstract][Full Text] [Related]
20. Usefulness of adjusting for clinical covariates to improve the ability of B-type natriuretic peptide to distinguish cardiac from noncardiac dyspnea. Rogers RK; Stoddard GJ; Greene T; Michaels AD; Fernandez G; Freeman A; Nord J; Stehlik J Am J Cardiol; 2009 Sep; 104(5):689-94. PubMed ID: 19699346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]